表紙
市場調查報告書
商品編碼
1066545

人類乳突病毒(HPV)治療藥的全球市場:2022年∼2026年

Global Human Papillomavirus (HPV) Therapeutics Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球人類乳突病毒(HPV)治療藥的市場規模在2022年∼2026年間,預測將成長到8億1,200萬美元,在預測期間中預計將以5.15%的年複合成長率增長。

市場成長的主要因素有疫苗的登場,HPV口服疫苗的開發,疾病的強勁進展。

本報告提供人類乳突病毒(HPV)治療藥的全球市場的整體分析,網羅市場規模與預測,趨勢,成長促進因素,課題,及約25供應商的分析。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2021年的市場規模
  • 市場預測:從2021年∼2026年的預測

第4章 波特的五力分析

  • 五力彙整
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 市場區隔:各給藥途徑

  • 市場區隔
  • 各給藥途徑的比較
  • 非口服:市場規模與預測(2021年∼2026年)
  • 局部:市場規模與預測(2021年∼2026年)
  • 各給藥途徑市場機會

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區的比較
  • 北美:市場規模與預測(2021年∼2026年)
  • 歐洲:市場規模與預測(2021年∼2026年)
  • 亞洲:市場規模與預測(2021年∼2026年)
  • 其他地區(ROW):市場規模與預測(2021年∼2026年)
  • 美國:市場規模與預測(2021年∼2026年)
  • 德國:市場規模與預測(2021年∼2026年)
  • 加拿大:市場規模與預測(2021年∼2026年)
  • 巴西:市場規模與預測(2021年∼2026年)
  • 中國:市場規模與預測(2021年∼2026年)
  • 各地區形勢的市場機會

第8章 推動要素,課題,及趨勢

  • 市場推動要素
  • 市場課題
  • 推動要素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bharat Biotech Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • ISA Pharmaceuticals BV
  • Merck and Co. Inc.
  • Serum Institute of India Pvt. Ltd.
  • Walvax Biotechnology Co. Ltd.
  • Xiamen Innovax Biotech Co. Ltd.

第11章 附錄

  • 調查範圍
  • 包含與排除清單
  • US$的匯率
  • 調查手法
  • 簡稱的清單
目錄
Product Code: IRTNTR72565

Technavio has been monitoring the human papillomavirus (HPV) therapeutics market and it is poised to grow by $ 812 mn during 2022-2026, progressing at a CAGR of 5.15% during the forecast period. Our report on the human papillomavirus (HPV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the advent of vaccines, the development of oral vaccines for HPV, and strong disease progression.

The human papillomavirus (HPV) therapeutics market analysis includes the route of administration segment and geographic landscape.

Technavio's human papillomavirus (HPV) therapeutics market is segmented as below:

By Route of Administration

  • Parenteral
  • Topical

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the R&D of new drugs for OH treatment as one of the prime reasons driving the human papillomavirus (HPV) therapeutics market growth during the next few years. Also, the use of combination therapy in oh treatment and the adoption of fludrocortisone as off-label first-line pharmacotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on human papillomavirus (HPV) therapeutics market covers the following areas:

  • Human papillomavirus (HPV) therapeutics market sizing
  • Human papillomavirus (HPV) therapeutics market forecast
  • Human papillomavirus (HPV) therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human papillomavirus (HPV) therapeutics market vendors that include AbbVie Inc., Bausch Health Companies Inc., Bharat Biotech Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., ISA Pharmaceuticals BV, Merck and Co. Inc., Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., and Xiamen Innovax Biotech Co. Ltd. Also, the human papillomavirus (HPV) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

  • 5.1 Market segments
  • Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • 5.2 Comparison by Route of Administration
  • Exhibit 26: Chart on Comparison by Route of Administration
  • Exhibit 27: Data Table on Comparison by Route of Administration
  • 5.3 Parenteral - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
  • 5.4 Topical - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Topical - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Route of Administration
  • Exhibit 36: Market opportunity by Route of Administration ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.10 Brazil - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 85: AbbVie Inc. - Overview
  • Exhibit 86: AbbVie Inc. - Business segments
  • Exhibit 87: AbbVie Inc. - Key offerings
  • Exhibit 88: AbbVie Inc. - Segment focus
  • 10.4 Bausch Health Companies Inc.
  • Exhibit 89: Bausch Health Companies Inc. - Overview
  • Exhibit 90: Bausch Health Companies Inc. - Business segments
  • Exhibit 91: Bausch Health Companies Inc. - Key offerings
  • Exhibit 92: Bausch Health Companies Inc. - Segment focus
  • 10.5 Bharat Biotech Ltd.
  • Exhibit 93: Bharat Biotech Ltd. - Overview
  • Exhibit 94: Bharat Biotech Ltd. - Product / Service
  • Exhibit 95: Bharat Biotech Ltd. - Key news
  • Exhibit 96: Bharat Biotech Ltd. - Key offerings
  • 10.6 GlaxoSmithKline Plc
  • Exhibit 97: GlaxoSmithKline Plc - Overview
  • Exhibit 98: GlaxoSmithKline Plc - Business segments
  • Exhibit 99: GlaxoSmithKline Plc - Key news
  • Exhibit 100: GlaxoSmithKline Plc - Key offerings
  • Exhibit 101: GlaxoSmithKline Plc - Segment focus
  • 10.7 Inovio Pharmaceuticals Inc.
  • Exhibit 102: Inovio Pharmaceuticals Inc. - Overview
  • Exhibit 103: Inovio Pharmaceuticals Inc. - Product / Service
  • Exhibit 104: Inovio Pharmaceuticals Inc. - Key offerings
  • 10.8 ISA Pharmaceuticals BV
  • Exhibit 105: ISA Pharmaceuticals BV - Overview
  • Exhibit 106: ISA Pharmaceuticals BV - Product / Service
  • Exhibit 107: ISA Pharmaceuticals BV - Key offerings
  • 10.9 Merck and Co. Inc.
  • Exhibit 108: Merck and Co. Inc. - Overview
  • Exhibit 109: Merck and Co. Inc. - Business segments
  • Exhibit 110: Merck and Co. Inc. - Key news
  • Exhibit 111: Merck and Co. Inc. - Key offerings
  • Exhibit 112: Merck and Co. Inc. - Segment focus
  • 10.10 Serum Institute of India Pvt. Ltd.
  • Exhibit 113: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibit 114: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibit 115: Serum Institute of India Pvt. Ltd. - Key offerings
  • 10.11 Walvax Biotechnology Co. Ltd.
  • Exhibit 116: Walvax Biotechnology Co. Ltd. - Overview
  • Exhibit 117: Walvax Biotechnology Co. Ltd. - Product / Service
  • Exhibit 118: Walvax Biotechnology Co. Ltd. - Key offerings
  • 10.12 Xiamen Innovax Biotech Co. Ltd.
  • Exhibit 119: Xiamen Innovax Biotech Co. Ltd. - Overview
  • Exhibit 120: Xiamen Innovax Biotech Co. Ltd. - Product / Service
  • Exhibit 121: Xiamen Innovax Biotech Co. Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 122: Inclusions checklist
  • Exhibit 123: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 124: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 125: Research methodology
  • Exhibit 126: Validation techniques employed for market sizing
  • Exhibit 127: Information sources
  • 11.5 List of abbreviations
  • Exhibit 128: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Route of Administration
  • Exhibits27: Data Table on Comparison by Route of Administration
  • Exhibits28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Topical - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Route of Administration ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: AbbVie Inc. - Overview
  • Exhibits86: AbbVie Inc. - Business segments
  • Exhibits87: AbbVie Inc. - Key offerings
  • Exhibits88: AbbVie Inc. - Segment focus
  • Exhibits89: Bausch Health Companies Inc. - Overview
  • Exhibits90: Bausch Health Companies Inc. - Business segments
  • Exhibits91: Bausch Health Companies Inc. - Key offerings
  • Exhibits92: Bausch Health Companies Inc. - Segment focus
  • Exhibits93: Bharat Biotech Ltd. - Overview
  • Exhibits94: Bharat Biotech Ltd. - Product / Service
  • Exhibits95: Bharat Biotech Ltd. - Key news
  • Exhibits96: Bharat Biotech Ltd. - Key offerings
  • Exhibits97: GlaxoSmithKline Plc - Overview
  • Exhibits98: GlaxoSmithKline Plc - Business segments
  • Exhibits99: GlaxoSmithKline Plc - Key news
  • Exhibits100: GlaxoSmithKline Plc - Key offerings
  • Exhibits101: GlaxoSmithKline Plc - Segment focus
  • Exhibits102: Inovio Pharmaceuticals Inc. - Overview
  • Exhibits103: Inovio Pharmaceuticals Inc. - Product / Service
  • Exhibits104: Inovio Pharmaceuticals Inc. - Key offerings
  • Exhibits105: ISA Pharmaceuticals BV - Overview
  • Exhibits106: ISA Pharmaceuticals BV - Product / Service
  • Exhibits107: ISA Pharmaceuticals BV - Key offerings
  • Exhibits108: Merck and Co. Inc. - Overview
  • Exhibits109: Merck and Co. Inc. - Business segments
  • Exhibits110: Merck and Co. Inc. - Key news
  • Exhibits111: Merck and Co. Inc. - Key offerings
  • Exhibits112: Merck and Co. Inc. - Segment focus
  • Exhibits113: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibits114: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibits115: Serum Institute of India Pvt. Ltd. - Key offerings
  • Exhibits116: Walvax Biotechnology Co. Ltd. - Overview
  • Exhibits117: Walvax Biotechnology Co. Ltd. - Product / Service
  • Exhibits118: Walvax Biotechnology Co. Ltd. - Key offerings
  • Exhibits119: Xiamen Innovax Biotech Co. Ltd. - Overview
  • Exhibits120: Xiamen Innovax Biotech Co. Ltd. - Product / Service
  • Exhibits121: Xiamen Innovax Biotech Co. Ltd. - Key offerings
  • Exhibits122: Inclusions checklist
  • Exhibits123: Exclusions checklist
  • Exhibits124: Currency conversion rates for US$
  • Exhibits125: Research methodology
  • Exhibits126: Validation techniques employed for market sizing
  • Exhibits127: Information sources
  • Exhibits128: List of abbreviations